Outcome of the Board Meeting held today, i.e., July 28, 2026

CIN: L27100TG1989PLC010122 ZENOTECH LABORATORIES LIMITED Registered Office & Factory: Survey No.250 -252 Turkapally Village, Genome Valley Road, Shamirpet Mandal, Medchal-Malkajgiri Dist., Turkapalliyadaram, Hyderabad - 500 101 Telangana, India. Tel: +91 90320 44584/ 585 Email: info@zenotech.co.in www.zenotechlab.com Date: July 28, 2026 BSE Limited Corporate Relationship Dept., Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 532039 Sub: Zenotech Laboratories Limited - Outcome of the Board Meeting held today, i.e., July 28, 2026 Further to the communication dated July 13, 2026, pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) this is to inform that the Meeting of the Board of Directors of the Company (“Board”) was held today, i.e., July 28, 2026, which commenced at 11:30 A.M. and concluded at 2:30 P.M., IST. The Board has, inter-alia: 1. Approved Unaudited Standalone Financial Results The Unaudited Standalone Financial Results for the quarter ended June 30, 2026, as approved pursuant to Regulation 33 of the Listing Regulations, along with the Limited Review Report of the Statutory Auditors, are annexed herewith as Annexure A. 2. Approved convening 37th Annual General Meeting The 37th Annual General Meeting (“AGM”) of the Company will be held on Friday, September 25, 2026, at 10:30 A.M. IST through Videoconferencing. The Notice of the AGM and the Annual Report will be released in due course. Shareholders are requested to get their information updated with the depositories (for shares held in demat) or with the Company’s RTA (for shares held in physical form), so that Notice of the AGM and the Annual Report can be received by email. For Zenotech Laboratories Limited (Abdul Gafoor Mohammad) Company Secretary & Compliance Officer ICSI Membership No. A22331 Encl: as above GS K A & Co. 4th floor, Red building, Chartered Accountants Above Shinhan Bank, Boat Club Road, Pune-411 001 Independent .-\uditor's Review Report On the Quarte.-ly l'naudited Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended Review Report To The Board of Directors Zcnotech Laboratories Limited I. We have re\ iewed the accompan~ ing statement of unaudited standalone tinancial results or /enotech Laboratories Limited (the "Company") for the quarter ended June 30. 2026 (the "Statement") attached here\vith. being submitt.::d by the Company pursuant to the n::quirements of Regulation 33 ol'the SEHI (l.isting Obligations and Disdosure Requirem.::nts) Regulations. 2015. as amended (tho.: "Listing Regulatinns"). 2. The Com pun) 's manago.:mo.:nt is responsible for the preparation or th.:: Statement in accordanco.: \\ ith the recognition and mcasun:ment principles laid down in Indian Accounting Standard 3-t (Ind AS 3~) "Into.:rim l:inancial Reporting" prescribed under Section 133 of the Companio::s AcL 2013 as amcndt:d. read \\ith rele\ant rules issued thereunder and other accounting principles generally accepted in India and in compliance\\ ith R.::gulation 33 of the Listing Regulations. rhc Statement has been uppi'U\t::d h~ the Com pan~ 's Board oi"Dirco.:tors. Our respnnsibilit) is to e'\prt:ss a conclusion on the Statement based on 3. We o.:onduct.:d our rc\ icw of the Statement in accordance with the Standard on Rc\ icw Engagements (SRE) 2~ I 0. "Revio.:\\ or lnt.::rim Financiaiinlormation Perlonn.:d b) the Independent Auditor of the Entity" issued b) th.:: Institute of Chartered Accountants oflndia. This standard requires that \\C plan and perrorm the IT\ ie\\ to obtain moderate assurance as to whether the Staterno.:nt is free of material misstatement. A re\.ie\\ or interim tinancial inlormation consists oJ'making inquiries. primaril) of persons responsible for tlnancial and accounting matters. and appl~ in g. anal~ tical and other r.::\. i.::w procedures. A re\ iC\\ is suhstantiall~ lo.:ss in scope than an audit conducted in accordance \Yith Standards on Auditing and consequently do.::s not enable us to obtain assurance that \\C \\ould become aware ol'all signitlcant matters that might he identified in an audit. Accordinglj. \II! do not express an audit opinion. ~- Bas.::d on our rcview conducted as above. nothing has come to our allention that causes us to bo::lieve that the accompanying Statement. prepared in accordance with the reo.:ognition and measurement principles laid dol\ n in the a lore said Indian Accounting Standards ('lnd AS') specitied under Section 133 of the Companies Act. 2013 as amended. read \-\ith rele1ant rules issued thereunder and other accounting principles generally accepted in India. has not disclosed the information required to be disclosed in terms of the Listing Regulations. including th.:: manner in which it is to be disclosed. or that it contains an) material misstatement. For G S K ..\ & Co. t47093W Place o t' signature: Pune Date: Jul) 28. 2026 ZENOTECH LA BORAT ORIES LIMITED CIN: L27100TG1989PLC010122 Survey No.250-252, Turkapally Village, Genome Valley Road, Shameerpet Mandai, Medchai-Malkajgiri District, Hyderabad-500101, Telangna Phone:+91 90320 44584/585/586 Website: www.zenotechlab.com Statement of unaudited standalone financial results for the quarter ended June 30, 2026 (Rs in lakhs. e~ccpt earning.' per shurc) Quarter ended Year ended Sl. 30.06.2026 31.03.2026 30.06.2025 31.03.2026 No. Particulars Unaudited Audited Unaudited Audited (Refer Note 6) I Revenue from operations 959.64 886.50 863.91 3,956.20 II Other operating income 101 58 101.56 100.41 405.16 Ill Other Income 43 57 59.65 58.84 230.90 IV Total Income U+ll+lln 1.104.79 1,047.71 1,023.16 4,592.26 Expenses a). Cost of materials consumed - b). Purchase of Stock-in-Trade . . c). Changes in inventories of finished goods, work-in-progress and stock-in-trade - - . . d). Employee benefit expenses 491.63 416.63 353.56 1,552 79 e). Depreciation and amortization expense 190.23 175.80 177.37 711 34 f). Other expenses 483.00 554.24 364.55 1.889.72 Total expenses 1,164.86 1.146.67 895.48 4,153,85 VI Profit/(Loss) before exceptional items and tax CIV-V) (60.07) (98.96} 127.68 438.41 VII Exceptional items 5.41 (19.51) VIII Profit/fLoss) before tax CVJ-VI)) (6007) 193.55\ 127.68 418.90 IX Tax expense a). Current tax - - 22.21 - b). Prior period tax 239.42 4893 c). Deferred tax (14.52) (17.89) 6.52 477.18 Total tax expense (IX) Cl4.52) 221.53 28.72 526.11 X Profit!( Loss) for the period (VIII-IX) (45.55) (315.08) 98.96 (107.21\ XI Other comprehensive Income a). Items that will not be reclassified to profit or loss 1.56 8.02 (0.59) 6.24 Re-measurement of the defined benefit obligations Less: Income tax (0.39) (2.02) . (1.57) b). Items that will be reclassified to profit or loss . . 0.17 Less: Income tax - . Total Other comprehensive income (a+b) 1.17 6.00 (0.42) 4.67 XII Total comprehensive income for the period (X+XJ) (44.38) (309.08) 98.54 (102.54) XIJI Paid-up equity share capital (Face value on I 0/-per share) 6.103.06 6.103.06 6.103.06 6.103.06 XIV Reserves i.e. Other equity 3.409.05 XV Earnings/ (loss) per share (on' 10/-each) (not annualised for quarter) a) Basic (0.07) (0 52) 0.16 (0.18) b) Diluted (0.07) 10.52) 0.16 (0 18) See accompanying notes to the unaudited financial results Notes: 1. The Statement of unaudited financial results for the quarter ended June 30, 2026, is drawn up in accordance with the Regulation 33 ofthe Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which \\as reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on July 28, 2026. These results have been subjected to limited revie\\ by statuto!) auditors who have expressed an unmodified review conclusion. 2. The above results have been prepared in accordance with the recogmtJOn and m [Showing first 8,000 characters — download PDF for full document]